Keros Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 367K | 385K | 14.3M | 18.2M | 211.2M | 3.0M | 388K | 37K |
| Cost of Goods Sold | 403K | 0 | 395K | 370K | 0 | 332K | 314K | 0 |
| Gross Profit | -36K | 385K | 13.9M | 17.8M | 211.2M | 2.7M | 74K | 37K |
| R&D Expenses | 16.1M | 17.9M | 19.5M | 43.5M | 48.7M | 45.6M | 49.2M | 40.5M |
| Operating Expenses | 25.8M | 29.7M | 29.3M | 57.6M | 59.2M | 56.0M | 58.7M | 50.5M |
| Operating Income | -25.9M | -29.3M | -15.4M | -39.8M | 152.0M | -53.3M | -58.7M | -50.4M |
| Other Income / Gains | 2.2M | 4.3M | 6.7M | 6.9M | 6.5M | 7.5M | 5.7M | 5.2M |
| Net Income | -23.7M | -23.5M | -7.3M | -30.7M | 148.5M | -46.0M | -53.0M | -45.3M |
| EPS (Diluted) | -0.64 | -0.86 | -0.18 | -0.76 | 3.66 | -1.14 | -1.47 | -1.25 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | -0.098 | 1.00 | 0.972 | 0.98 | 1.00 | 0.891 | 0.191 | 1.00 |
| General And Administrative Expenses | 10.1M | 11.7M | 10.1M | 14.5M | 10.5M | 10.7M | 9.8M | 10.0M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 10.1M | 11.7M | 10.1M | 14.5M | 10.5M | 10.7M | 9.8M | 10.0M |
| Other Expenses | -403K | 0 | -395K | -370K | 0 | -332K | -314K | 0 |
| Cost And Expenses | 26.2M | 29.7M | 29.6M | 58.0M | 59.2M | 56.3M | 59.0M | 50.5M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 403K | 400K | 395K | 370K | 344K | 332K | 314K | 306K |
| Ebitda | -23.3M | -24.6M | -8.3M | -32.5M | 158.8M | -29.1M | -52.6M | -45.0M |
| Ebitdaratio | -63.501 | -63.831 | -0.583 | -1.792 | 0.752 | -9.58 | -135.675 | -1K |
| Operating Income Ratio | -70.51 | -76.026 | -1.079 | -2.192 | 0.72 | -17.506 | -151.178 | -1K |
| Income Before Tax | -23.7M | -25.0M | -8.7M | -32.9M | 158.5M | -45.7M | -53.0M | -45.3M |
| Income Before Tax Ratio | -64.599 | -64.87 | -0.61 | -1.812 | 0.75 | -15.032 | -136.485 | -1K |
| Income Tax Expense | 0 | -1.5M | -1.4M | -2.2M | 10.0M | 300K | 0 | 0 |
| Net Income Ratio | -64.599 | -60.938 | -0.51 | -1.69 | 0.703 | -15.13 | -136.485 | -1K |
| Epsdiluted | -0.63 | -0.38 | -0.18 | -0.76 | 3.62 | -1.14 | -1.47 | -1.25 |
| Weighted Average Shs Out | 37.2M | 37.2M | 40.6M | 40.6M | 40.6M | 40.3M | 36.1M | 36.1M |
| Weighted Average Shs Out Dil | 37.9M | 37.9M | 40.6M | 40.6M | 41.0M | 40.3M | 36.1M | 36.1M |